Mammography Accreditation

Preparing for ACR Accreditation

ACR Accreditation is a valuable tool for maintaining excellence in everything from operations to patient care. To prepare for your application:

Confirm that your medical imaging staff has the appropriate experience and qualifications.
Perform all quality control tests as established by ACR and your Mammography unit manufacturer.
Work with your supervising physician to select your best Mammography images for submission.

The comprehensive information you need to guide you through all of the above, including complete program requirements and testing instructions, can be found here.

Accreditation forms and quick links

Start your application

Your Roadmap to Accreditation Submission

Once you’ve applied and received your testing materials, the following documents can help you navigate the next steps to ACR Accreditation.

Accreditation Process for New and Renewing Facilities Mammography Accreditation Checklist and Milestones Technologist Quality Control Forms Medical Physicist Evaluation Forms

Fees

See the complete breakout of pricing by units, modules and sites including multiple modality discounts. Learn More

Accreditation Support

Still have questions?

Submit a ticket

Announcements

JANUARY 31, 2024
The US Food and Drug Administration (FDA) has posted a new information document to assist mammography facilities subject to the Mammography Standards Act (MQSA) as they prepare for the September 10, 2024 effective date of the March 10, 2023, final rule amending MQSA regulations
March 29, 2024
FDA Approves Mammography Accreditation Fee Schedule Change
April 17, 2024
The ACR forwarded the following questions received from facilities and members to the FDA for review and response regarding the 2023 Amended MQSA Regulations, we hope this assists in preparation for the September 10, 2024, effective date
August 13, 2024
ACR® Town Hall, 2023 Amended MQSA Final Regulations — Thank you for attending the ACR® Town Hall, 2023 Amended MQSA Final Regulations. The recording is now available on demand. As a reminder, the new MQSA requirements become effective on Sept. 10. Watch on Demand now
September 4, 2024
Mammography Quality Standards Act and Regulation Amendments: Small Entity Compliance Guide — The U.S. Food and Drug Administration (FDA) issued a Small Entity Compliance Guide (SECG) to assist small entities, including mammography facilities, in complying with the FDA’s March 2023 final rule (“2023 MQSA Rule”) amending regulations under the Mammography Quality Standards Act of 1992 (MQSA) and the Federal Food, Drug, and Cosmetic Act. The amendments, which become effective September 10, 2024, will help modernize the regulations by incorporating current science and mammography best practices. Read the SECG
NOVEMBER 1, 2024
ACR Offers International Recognition for Quality and Safety ACR Accreditation will soon offer non-U.S. imaging facilities recognition for meeting current ACR accreditation standards. Facilities will submit self-assessment documentation for verification. No clinical or phantom images required.Watch for updates
NOVEMBER 25, 2024
Changes to ACR MAP Testing Packet – Personnel Qualification Forms The Food and Drug Administration (FDA) has approved the removal of Personnel Qualification Forms from the ACR Mammography Accreditation Program (MAP) applications effective Nov. 25, 2024. The ACR requested this change in process with the FDA to help decrease burden at already stressed mammography facilities. Although the facility will no longer be required to submit the personnel qualification forms to the ACR for the Interpreting Physicians, Technologists or Medical Physicists, the facility is still required under federal law (MQSA) to ensure that all personnel meet these requirements prior to performing mammography. Please see the MAP Testing Overview on how to proceed with the accreditation testing materials.Learn more